14th World Conference on Lung Cancer

Plenary Sessions

* The Lung Cancer Epidemic
* Lung Cancer in Never-Smokers
* State of the Art

Education Sessions

* Smoking Cessation & Lung Cancer Stigma
* Imaging Aspects of Staging in Lung Cancer
* Treatment of Mesothelioma
* Pain Management
* Assessment and Measurement of Outcomes in Supportive Care
* Diagnosis and Treatment Decisions
* Radiotherapy Issues in Small Cell Lung Cancer
* Concurrent CT-RT for LA-NSCLC – Managing Toxicity and Follow-Up
* Biology of Radiotherapy – An Update
* Imaging for Radiotherapy Planning and Adaptive Planning
* Borderline Operable NSCLC
* Quality Control and Concentration of Care
* Surgery after Induction Therapy IIIA
* TNM 7th Edition – What Should Doctors Do?
* Advanced Thymoma
* Nurses Role in Lung Cancer

Mini Symposium Sessions

* Stem Cells in the Mouse
* Signaling in Lung Cancer
* Chemoprevention: New Approaches in High Risk Populations
* New Applications of Imaging Techniques
* Thymoma
* Novel Therapies in NSCLC
* EGFR Resistance
* K-Ras Role in NSCLC
* Tumor and Host
* Combination of Targeted Agents with Chemotherapy – A Challenging Task
* Symptom Control – Translating Basic Research to Bedside
* Organization of Supportive and Palliative Care
* Methodological Aspects of Mutation Analysis
* How Molecular Pathology May Affect Diagnosis and Treatment of Lung Cancer
* Carcinogenesis and Metastasis
* Image Guided Tissue Characterization
* Developments in High Dose Radiotherapy for Lung Cancer
* Molecular Screening
* Nodule Management
* Issues Surrounding the Use of PFS as a Primary Endpoint
* The Use of Biomarkers in Clinical Trial Design
* Design of Phase II Clinical Trials: Single Arm, Randomized, Multi Arm?
* New Kids on the Block (Surgery)
* Tracheal Tumors
* Oligometastatic Disease
* Screening by Low Dose CT
* 40+ Years Experience in Lung Cancer: What Brings the Future?
* Global Lung Cancer Coalition and Longkanker Informatiecentrum: Lung Cancer - Effecting Change

Grand Rounds and Pro-Con Sessions

* Endoscopic Highlights
* Early Lung Cancer
* Mesothelioma – Oncological and Supportive Management
* Boundaries of Bronchoscopy - Central Hilar Lesions
* Intra-Operative Decision Making
* Difficult Surgery

Meet the Expert Sessions

* Chemoprevention: Randomized Studies & What Have We Learned?
* Lung Cancer in Never-Smokers: Implications for Treatment
* Small Cell Lung Cancer, Para Neoplastic Syndromes
* Critical Perspective on the Treatment of Stage IV Disease, Cost-Effectiveness Analysis New Drugs
* Progressive Disease During TKI
* Treatment of Mesothelioma - New Pathways
* Adenocarcinoma Classification Update: Pathology - Radiology
* Pathology for Non Pathologists
* ALK Translocations
* Genomics in Lung Cancer
* Molecular Markers in Lung Cancer
* Pre-Neoplastic Disease
* Integral Approach Nodal/Mediastinal Disease PET/EBUS/EUS
* Major Airway Problems
* How to Report PET
* New Imaging Techniques
* I Wish ... Seconds to Disaster Cases to Learn From
* New Technology in Radiotherapy - We Do Not Need Phase III Trials
* How I Practice Concurrent CT-RT for Stage III NSCLC: Patient Selection, Toxicity Management and Outcomes at my Center?
* Considerations in Setting up a SBRT Program at my Clinic
* Pulmonary Risk Assessment for Curative Therapy
* Synchronic Metastases in Brain..., When is Aggressive Treatment Justified?
* Combined Modality Treatment, Especially Concomitant Chemoradiation: Which Chemotherapy? Which Radiotherapy Fractionation Scheme? Toxicities?
* Bi-Versus Trimodality Therapy for Locally Advanced NSCLC
* Superior Sulcus Tumor with N2 Disease
* Surgery for Mesothelioma Pleurectomy - EPP
* Molecular Tools, Tissue Requirements
* Sleeve Resections
* Lymphnode Dissection
* Chest Wall Tumors, Non Pancoast
* Rare Mediastinal Tumors
* Chemotherapy
* How to Run a Non Smoking Out Patient Clinic
* Second Line Treatment at Relapse of Small Cell
* Pulmonrary Cytology, Diagnosis and Molecular Approaches

Programme Objectives

At the 14th World conference on Lung Cancer, our objectives are to:

* Analyze recent advances in prevention, imaging, and early detection of lung cancer
* Identify advances in the molecular biology and pharmacogenomics of lung cancer and their effect on personalized lung cancer treatment
* Apply the new IASLC staging system to thoracic malignancies
* Implement a therapeutic plan to include surgery, radiotherapy, systemic therapy or a combination of these based on stage, clinical and molecular features
* Interpret the results from recent clinical trials related to lung cancer, mesothelioma, and thymoma
* Define palliative care options for individuals with lung cancer
* Analyze the efficacy of tobacco control methods being used throughout the world